Description

Concerta Tablets

Concerta Extended-Release Tablets are a prescription central nervous system (CNS) stimulant containing methylphenidate hydrochloride. Manufactured by Janssen Pharmaceuticals, Concerta is engineered with a specialized Osmotic Controlled-Release Oral Delivery System (OROS technology) designed to deliver steady therapeutic coverage.

Technical Specifications & Strength

• Active Substance: Methylphenidate hydrochloride.

• Formulation Type: Extended-release (XR / OROS). The tablet does not dissolve traditionally. Instead, moisture from the digestive tract activates an internal osmotic pump, trickling medication steadily over approximately 10 to 12 hours.

Available Dosage Strengths:

• 18 mg (Capsule-shaped, yellow tablet, typically imprinted with “alza 18”).

• 27 mg (Capsule-shaped, gray tablet, typically imprinted with “alza 27”).

• 36 mg (Capsule-shaped, white tablet, typically imprinted with “alza 36”).

• 54 mg (Capsule-shaped, brownish-red tablet, typically imprinted with “alza 54”).

• Administration: Must be swallowed whole once daily in the morning with or without food. Tablets must never be crushed, chewed, or divided, as breaking the outer shell destroys the extended-release mechanism and releases the full dose immediately.

Primary Clinical Indications

• Attention-Deficit/Hyperactivity Disorder (ADHD): Indicated for the treatment of ADHD in pediatric patients (aged 6 years and older), adolescents, and adults up to age 65. It enhances focus, organizational skills, and impulse control by elevating dopamine and norepinephrine presence in key areas of the brain.

Safety and side effects

Although, like all medicines, it can cause side effects. Common side effects include:

• Sleep problems
• Decreased appetite
• Headache
• Anxiety

Although if you experience serious side effects, contact a doctor immediately.